Entering text into the input field will update the search result below

OncoCyte reports Q2 results

  • OncoCyte (NASDAQ:OCX): Q2 EPS of -$0.10
  • Cash and equivalents of $4M
  • Press Release

Recommended For You

More Trending News

About OCX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
OCX--
OncoCyte Corporation